Cargando…
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200127/ https://www.ncbi.nlm.nih.gov/pubmed/32376396 http://dx.doi.org/10.1016/j.autrev.2020.102564 |
| _version_ | 1783529274748174336 |
|---|---|
| author | Antinori, Spinello Bonazzetti, Cecilia Gubertini, Guido Capetti, Amedeo Pagani, Cristina Morena, Valentina Rimoldi, Sara Galimberti, Laura Sarzi-Puttini, Piercarlo Ridolfo, Anna Lisa |
| author_facet | Antinori, Spinello Bonazzetti, Cecilia Gubertini, Guido Capetti, Amedeo Pagani, Cristina Morena, Valentina Rimoldi, Sara Galimberti, Laura Sarzi-Puttini, Piercarlo Ridolfo, Anna Lisa |
| author_sort | Antinori, Spinello |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7200127 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72001272020-05-06 Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Antinori, Spinello Bonazzetti, Cecilia Gubertini, Guido Capetti, Amedeo Pagani, Cristina Morena, Valentina Rimoldi, Sara Galimberti, Laura Sarzi-Puttini, Piercarlo Ridolfo, Anna Lisa Autoimmun Rev Article Elsevier B.V. 2020-07 2020-05-05 /pmc/articles/PMC7200127/ /pubmed/32376396 http://dx.doi.org/10.1016/j.autrev.2020.102564 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Antinori, Spinello Bonazzetti, Cecilia Gubertini, Guido Capetti, Amedeo Pagani, Cristina Morena, Valentina Rimoldi, Sara Galimberti, Laura Sarzi-Puttini, Piercarlo Ridolfo, Anna Lisa Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title_full | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title_fullStr | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title_full_unstemmed | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title_short | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| title_sort | tocilizumab for cytokine storm syndrome in covid-19 pneumonia: an increased risk for candidemia? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200127/ https://www.ncbi.nlm.nih.gov/pubmed/32376396 http://dx.doi.org/10.1016/j.autrev.2020.102564 |
| work_keys_str_mv | AT antinorispinello tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT bonazzetticecilia tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT gubertiniguido tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT capettiamedeo tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT paganicristina tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT morenavalentina tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT rimoldisara tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT galimbertilaura tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT sarziputtinipiercarlo tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia AT ridolfoannalisa tocilizumabforcytokinestormsyndromeincovid19pneumoniaanincreasedriskforcandidemia |